The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of patients (pts) with metastatic non-clear-cell renal cell carcinoma (nccRCC) treated with pazopanib.
Marc Ryan Matrana
Honoraria - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Ali Baiomy
No relevant relationships to disclose
Khaled M. Elsayes
No relevant relationships to disclose
Aditya Shetty
No relevant relationships to disclose
Purnima Sravanti Teegavarapu
No relevant relationships to disclose
Lianchun Xiao
No relevant relationships to disclose
Eric Jonasch
No relevant relationships to disclose
Nizar M. Tannir
Research Funding - GlaxoSmithKline